Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02401542
Title Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma (FIERCE-21)
Acronym FIERCE-21
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Rainier Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP

Facility Status City State Zip Country Details
Research Site Gilbert Arizona 85234 United States Details
Research Site Goodyear Arizona 85338 United States Details
Research Site Duarte California 91010 United States Details
Research Site Miami Florida 33140 United States Details
Reaserach Site Fort Wayne Indiana 46845 United States Details
Research Site Louisville Kentucky 40202 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site Rochester Minnesota 55905 United States Details
Research Site Syracuse New York 13210 United States Details
Research Site Dallas Texas 75390-9110 United States Details
Research Site Olomouc 77900 Czechia Details
Research Site Prague 12808 Czechia Details
Research Site Ancona 60126 Italy Details
Research Site Catania 95123 Italy Details
Research Site Milan 20132 Italy Details
Research Site Milan 20133 Italy Details
Research Site Milan 20141 Italy Details
Research Site Modena 41124 Italy Details
Research Site Napoli 80131 Italy Details
Research Site Negrar 37024 Italy Details
Research Site Siena 53100 Italy Details
Research Site Gwangju 61469 Korea, Republic of Details
Research Site Incheon 405-760 Korea, Republic of Details
Research Site Seongnam-si 13620 Korea, Republic of Details
Research Site Seoul 02841 Korea, Republic of Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Badalona 08916 Spain Details
Research Site Barcelona 08003 Spain Details
Research Site Barcelona 08026 Spain Details
Research Site Barcelona 08036 Spain Details
Research Site Barcelona 08908 Spain Details
Research Site Granada 18014 Spain Details
Research Site Lugo 27003 Spain Details
Research Site Madrid 28007 Spain Details
Research Site Madrid 28033 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Madrid 28046 Spain Details
Research Site Madrid 28050 Spain Details
Research Site Oviedo 33011 Spain Details
Research Site Pamplona 31008 Spain Details
Research Site Valencia 46009 Spain Details
Research Site Vigo 36204 Spain Details
Research Site Uppsala 751 85 Sweden Details
Research Site Kaohsiung 81362 Taiwan Details
Research Site Kaohsiung 83301 Taiwan Details
Research Site Taichung 40447 Taiwan Details
Research Site Taichung 435 Taiwan Details
Research Site Tainan 704 Taiwan Details
Research Site Taipei 110 Taiwan Details
Research Site Taipei 11217 Taiwan Details
Research Site Taoyuan 333 Taiwan Details
Research Site Adana 01330 Turkey Details
Research Site Ankara 06590 Turkey Details
Research Site Antalya 07059 Turkey Details
Research Site Bursa 16059 Turkey Details
Research Site Edirne 22030 Turkey Details
Research Site İstanbul 34732 Turkey Details
Research Site İzmir 35340 Turkey Details
Research Site Malatya 44280 Turkey Details
Research Site London SW36JJ United Kingdom Details
Research Site Preston PR29HT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field